ArticleJournal for immunotherapy of cancer2021

Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma.

Jonathan E Brammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.